PALM SPRINGS, Calif. (KESQ) -The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate cancer cases on the rise across the nation ...
Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...
Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results